Clinical trial

Precision Regional Node Irradiation for Sentinel Node-positive Breast Cancer

NCT06583655

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-10-01

PhaseNA

Study timeline

Study start (actual)2024-10-01Date precision: day

Registry last updated2026-08-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancer Invasiveunresolved

Interventions

SLND(clinical low risk)RADIATION

SLND(clinical high risk, genomic low risk)RADIATION

SLND alone ,clinical high risk and genomic high risk groupRADIATION

Sentinel Lymph Node Dissection(SLND) + axillary lymph node dissection(ALND)RADIATION

Sponsors & collaborators

Ruijin Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06583655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.